Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma

Several biomarkers such as tumor mutation burden (TMB), neoantigen load (NAL), programmed cell‐death receptor 1 ligand (PD‐L1) expression, and lactate dehydrogenase (LDH) have been developed for predicting response to immune checkpoint inhibitors (ICIs) in melanoma. However, some limitations includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Junjie, Ding, Yongfeng, Wu, Mengjie, Chen, Yanyan, Lyu, Xiadong, Lu, Jun, Wang, Haiyong, Teng, Lisong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666739/
https://www.ncbi.nlm.nih.gov/pubmed/32969604
http://dx.doi.org/10.1002/cam4.3481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666739/
https://www.ncbi.nlm.nih.gov/pubmed/32969604
http://dx.doi.org/10.1002/cam4.3481

Ejemplares similares